Content is not available

Rigel Pharmaceuticals

South San Francisco,  CA 
United States
http://www.rigel.com/
  • Booth: 18135

Rigel's first FDA approved product TAVALISSE® (fostamatinib disodium hexahydrate) tablets, is the only oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. It is now also commercially available in Europe and Canada TAVALISSE is in a Phase 3 clinical trial for the treatment of warm antibody autoimmune hemolytic anemia (AIHA) and a Phase 3 clinical trial for the treatment of hospitalized COVID-19 patients To see the full Prescribing Information visit TAVALISSEhcp.com

 Show Specials

 Press Releases

 Products

  • Rigel Pharmaceuticals, Inc.
    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing, and providing, novel small molecule drugs that significantly improve the lives of patients with hematologic disorders, cancer, and rare immune diseases....

  • Learn more about TAVALISSE®
    TAVALISSE® (fostamatinib disodium hexahydrate) tablets, is the only oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment....

Categories

Cancer Types
  • Hematologic Cancers
    • Categories:
  • Biotechnology
  • Clinical Trials
  • Drug Development
  • Pharmaceutical
    • << Previous Back to the Search Next >>
    Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined